Startup · $38.4m raised · AI
Clinical AI platform for medical imaging triage
Every investor coverage indicates participated in a round Aidoc raised.
| Investor | Rounds | Invested |
|---|---|---|
| Square Peg Capital | Series B | - |
Companies Aidoc acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Aidoc. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Square Peg's half-year investor letter reports two funds reaching final close, three exits including Talon.One's sale to Adyen, realisations past US$1bn, and a framework for judging AI disruption across its portfolio.
Square Peg reports 30% portfolio growth, US$1bn+ cumulative realisations, US$138m returned this half, closes two new funds, and outlines an AI disruption framework.
Square Peg's half-year investor letter reviews its accelerating AI investing, portfolio companies' progress including several completed raises, listed fund returns, a new data hire, and ongoing fundraising for its 2025 vintage funds.
In its half-year letter, Square Peg explains how it picks AI founders, reports several portfolio companies' recent raises, flags a data engineering hire, and says fundraising for its next funds is well advanced.
Also Tech Funding News - Australia·Forbes Australia·SmartCompany·SmartCompany·Startup Daily·Startup Daily
Square Peg's half-year letter to investors reviews 2024: $146m invested, $220m returned via five exits, fund value up to $3.25bn, plus portfolio raises at Rokt, Constantinople, Exodigo, Cuttable and Supabase.
Square Peg's half-year investor letter reviews 2024: portfolio growth, $220m returned across five exits, a Rokt secondary at a $3.5bn valuation, and recent raises at Constantinople, Exodigo, Cuttable and Supabase.
Also Square Peg Capital·SmartCompany·Startup Daily·SmartCompany·Australian FinTech·Forbes Australia·Dealroom·Dealroom
Square Peg profiles its Global Tech Fund, a listed-markets strategy applying its venture investing approach to early-stage public tech companies, and outlines its team, edge, and focus on fintech, software and AI.
Also Square Peg Capital
Square Peg's latest letter to investors reviews 2023 performance, recalls early bets on Canva and Airwallex, and introduces three hires across fundraising, public-markets investing, and people functions.
Square Peg's half-year letter to investors reviews 2023: fewer new bets, portfolio revenue milestones led by Canva, an AI investment thesis, conditions in Israel, and three new hires.
Square Peg announces James Tynan as its newest partner, with reflections from Vow's CEO and Square Peg's investment team on his approach, plus his board roles at Partly and Neara and sector outlook.
Square Peg Capital has closed its fifth fund at $550 million, bringing total funds raised to about $1.6 billion, with superannuation funds among its backers and investments across Australia, Southeast Asia and Israel.
Square Peg's retrospective of 2019: five new portfolio companies, several large rounds it led or co-led, two acquisitions, two IPOs, new team members, and its capital deployed across new and follow-on deals.
Also Startup Daily·Square Peg Capital·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·SmartCompany
Square Peg's investment notes explain why it led Aidoc's US$27 million Series B, covering the founders' background, the strain on radiologists, and how the company's imaging AI improves patient care.
Also Square Peg Capital
Square Peg Capital's investment note on leading Doctor Anywhere's US$27 million Series B with co-leads EDBI and IHH Healthcare, describing the Singapore telehealth platform's integrated Southeast Asian care delivery business.
Square Peg's investment note recounts co-leading HealthMatch's $6 million Series A after an accelerated five-day process, profiling founder Manuri Gunawardena's clinical trial matching platform and existing backer Tempus Partners.
Square Peg Capital's year-in-review recaps its 2021 portfolio: raises it led or joined, SPAC listing decisions, Vend's acquisition, new investment-team hires, and its newsletter and podcast output.
Also Cut Through Venture·Startup Daily·SmartCompany·SmartCompany·Startup Daily·Techboard·Startup Daily·SmartCompany·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·Startup Daily·SmartCompany·SmartCompany·SmartCompany·Startup Daily·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Startup Daily·SmartCompany·SmartCompany·Startup Daily·Startup Daily·SmartCompany·myzeller.com·@AuManufacturing·Australian FinTech·Forbes Australia·Dealroom·rswebsols.com·Crunchbase News·TechCrunch Australia